Metformin for the Treatment of Microvascular Dysfunction After Gestational Diabetes
Status: Recruiting
Location: See location...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY
The purpose of this investigation is to examine the mechanisms mediating vascular dysfunction in women who have had gestational diabetes and how metformin may be a valuable treatment tool to improve microvascular function in these women before the onset of disease.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:
• ≥12 weeks and ≤5 years postpartum
• history of GDM or healthy pregnancy
Locations
United States
Iowa
University of Iowa
RECRUITING
Iowa City
Contact Information
Primary
Anna Stanhewicz, PhD
anna-stanhewicz@uiowa.edu
3194671732
Time Frame
Start Date: 2024-09-11
Estimated Completion Date: 2028-06-30
Participants
Target number of participants: 30
Treatments
Active_comparator: metformin
Placebo_comparator: placebo
Related Therapeutic Areas
Sponsors
Leads: Anna Stanhewicz, PhD